Navigation Links
Allergy & Asthma Network and Avella Specialty Pharmacy Highlight Risks Associated with Latex Allergies and Latex in Healthcare
Date:3/28/2017

VIENNA, Va. and PHOENIX, March 28, 2017 /PRNewswire/ -- Today, Allergy & Asthma Network and Avella Specialty Pharmacy released a new white paper to underscore the significant risks related to latex allergies and the use of latex in healthcare. Specifically, there is substantial confusion as to the meaning of "latex free" in healthcare. In fact, the FDA has urged manufacturers to drop the term "latex free" or a "does not contain latex" claim from labels, because of the challenge to ensure a product is completely devoid of natural rubber latex proteins that cause allergic reactions. According to the FDA, these labeling techniques are not sufficiently specific, not necessarily scientifically accurate, and may be misunderstood and applied too widely.

"Patient and physician safety is our highest priority, and we're pleased to collaborate with Allergy & Asthma Network to shine a spotlight on the risks related to latex allergies and the use of latex in healthcare," said Rebecca Shanahan, CEO of Avella Specialty Pharmacy. "Working in healthcare, it is vitally important to be aware of – and prepare for – all allergies related to the medications and products we use daily. We hope this white paper will equip caregivers with the information they need to ensure their safety and the safety of their patients."

Continue Reading
Latex White Paper Cover
Latex White Paper Cover

"We commend Avella Specialty Pharmacy for its leadership around the important issue of safeguarding against adverse effects related to latex allergies and the use of latex in healthcare," said Tonya Winders, President & CEO of Allergy & Asthma Network. "When working with patients who have latex allergies, healthcare personnel must make efforts to ensure a latex-safe environment and therapy regimen. Allergy & Asthma Network is always looking for new and better ways to promote patient and healthcare professional safety, so we welcome partnerships like this with thoughtful healthcare stakeholders and pharmacies, like Avella."

Co-authors of the new white paper, entitled "Latex Free Claims: A White Paper on the Risks Associated with Latex Allergies and Latex in Healthcare," include latex allergy expert and co-founder of the former American Latex Allergy Association, Sue Lockwood, and Dr. Robert Hamilton, M.S., Ph.D. of Allergy & Asthma Network, along with Avella Specialty Pharmacy's Dr. Eric Sredzinski, Pharm.D., AAHIVP, and Dr. Jenna Vaughn, Pharm.D., PGY1.

To download the white paper, please visit: www.avella.com/latex

About Avella Specialty Pharmacy
Headquartered in Phoenix, Arizona, Avella is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine's 2016 list of the 5,000 fastest-growing private companies in the country included Avella for the tenth consecutive year and also recognized Avella as the fastest-growing woman-led company in 2015. In addition, the Arizona Corporate Excellence Awards named Avella Specialty Pharmacy as the second fastest-growing private company based in the state in 2015. For more information, please visit www.avella.com.

About Allergy & Asthma Network
Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. Allergy & Asthma Network specializes in sharing family-friendly, medically accurate information through its award-winning magazine Allergy & Asthma Today, E-newsletter, AllergyAsthmaNetwork.org and numerous community outreach programs. Follow Allergy & Asthma Network on Facebook and Twitter @AllergyAsthmaHQ. Join the Network at AllergyAsthmaNetwork.org/join.

Media Contact


Maureen Shanahan  

Chris Thatcher

mshanahan@skdknick.com 

cthatcher@5wpr.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/allergy--asthma-network-and-avella-specialty-pharmacy-highlight-risks-associated-with-latex-allergies-and-latex-in-healthcare-300430641.html


'/>"/>
SOURCE Avella Specialty Pharmacy
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Allergies: standardisation, regulation and clinical trials breakthroughs with Stallergenes Greer, HAL Allergy, Nestle & LETI
2. Global Allergy Partnering 2010 to 2017
3. CSRAs DynPort Vaccine Company to Help Advance Medical Products for the National Institute of Allergy and Infectious Diseases
4. Five Things to Know About Penicillin Allergy
5. Allergy Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
6. Tolerability Data for Shires CUVITRU Accepted for Oral Presentation at the American College Of Allergy, Asthma & Immunology Annual Meeting
7. New Hospital Guidelines: Assess Penicillin Allergy To Ensure Optimal Antibiotic Use
8. Penicillin Allergy Is Overstated
9. Indiana Voters Oppose Prescription Requirements for Popular Cold and Allergy Medicines
10. Global Immunoprotein Diagnostic Testing Market 2015-2019 - Infectious Disease, Oncology and Endocrine, Autoimmune & Allergy Testing
11. How Penicillin Allergy Skin Testing Helps Combat A Growing Public Health Threat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology:
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 ... ... Certified Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce ... interested in building collagen and elastin in their face, neck, and body through ...
(Date:5/23/2017)... ... 2017 , ... New patients from Charleston, SC, are now welcome to receive ... Pleasant, SC, with or without a referral. A full mouth reconstruction can transform the ... in Charleston, SC. Those who suffer from gum disease, misaligned teeth or jaw ...
(Date:5/23/2017)... ... May 23, 2017 , ... Patients in need of a ... practice to schedule an appointment, with or without a referral. Dr. Cotey is a ... to pediatric patients as a healthy alternative to a tooth extraction. , When a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... 22, 2017 , ... OSF Ventures, the corporate investment arm ... early stage company in San Francisco that has developed software to individualize treatment ... Fund acted as the lead investor in the round. , Medicine is ...
Breaking Medicine News(10 mins):